Figure 1From: Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine The body weight (A) and fasting blood glucose (B) before and after berberine treatment in the rats (n = 8, in each group). Data represent mean ± S. D. (n = 8). *P < 0.05, **P < 0.01 versus the control group; #P < 0.05 versus DM group.Back to article page